Sector consensus Myriad Genetics, Inc.
Stocks
MYGN
US62855J1043
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
16:00:00 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 3.160 USD | -0.63% |
|
-1.25% | -48.62% |
| 07-30 | Myriad Genetics, Inc., Q2 2026 Earnings Call, Jul 30, 2026 | |
| 07-30 | Myriad Genetics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | 3.769 | +19.26% | 8 | |||||
| 194.29 | +20.3% | 24 | ||||||
| 79.04 | +5.04% | 14 | ||||||
| 49.54 | -19.5% | 13 | ||||||
| 27 | +5.35% | 12 | ||||||
| 107.16 | +6.34% | 9 | ||||||
| 66.07 | +26.66% | 10 | ||||||
| 71.66 | -6.47% | 14 | ||||||
| 38.19 | +15.47% | 4 | ||||||
| 129.6 | +35.71% | 5 | ||||||
| - | 22.02 | +40.61% | 1 | |||||
| 24.68 | +49.85% | 2 | ||||||
| - | - | 53.81 | -3.31% | 1 | ||||
| 44 | +31.34% | 9 | ||||||
| Average | 65.06 | +16.19% | 9 | ||||||
| Weighted average by Cap. | 102.03 | +10.72% | 15 |
- Stock Market
- Stocks
- MYGN Stock
- Sector Myriad Genetics, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
